Understanding Semaglutide Side Effects: Tirzepatide CAS 2023788-19-2 Supplier

Tirzepatide is a high-purity peptide compound with CAS number 2023788-19-2, specifically developed for research applications. With a purity exceeding 99%, this pharmaceutical-grade material offers researchers a reliable compound for studying GLP-1 receptor agonists and their effects.

While semaglutide side effects have been widely documented in clinical studies, tirzepatide presents a distinct molecular structure (C225H348N48O68) with potential research applications in metabolic studies. The compound appears as a white powder and should be stored in cool, dry conditions to maintain stability.

Researchers investigating semaglutide side effects may find comparative studies with tirzepatide valuable, as both compounds target similar metabolic pathways. This peptide has shown promise in preclinical studies for various applications, though all research should be conducted in compliance with local regulations.

The molecular weight of 4813 g/mol and EC number 200-001-8 provide precise identification for laboratory use. As with all research compounds, proper handling procedures should be followed, and studies should be designed with consideration of potential effects similar to semaglutide side effects.

This product is supplied for research purposes only and is not intended for human consumption. Researchers should consult all relevant literature regarding GLP-1 receptor agonists, including data on semaglutide side effects, when designing studies with this compound.